Erythropoietin protects against 6-hydroxydopamine-induced dopaminergic cell death

Journal of Neurochemistry

Volumn 96, Issue 2, 2006, Pages 428-443

  Signore, Armando P ^a   Weng, Zhongfang ^a   Hastings, Teresa ^a   Van Laar, Amber D ^a   Liang, Qinghua ^a   Lee, Yong J ^a   Chen, Jun ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Neuroprotection; Parkinson's disease; Serine threonine kinase (Akt); Substantia nigra pars compacta

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CASPASE 3; CASPASE 9; DNA FRAGMENT; ERYTHROPOIETIN; ERYTHROPOIETIN ANTIBODY; ERYTHROPOIETIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; NEUROPROTECTIVE AGENT; NEUROTOXIN; OXIDOPAMINE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; BIOLOGICAL MARKER; DOPAMINE; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DEATH; CELL STRAIN MN9D; CONTROLLED STUDY; DEGENERATIVE DISEASE; DOPAMINERGIC ACTIVITY; DOPAMINERGIC NERVE CELL; ENZYME ACTIVATION; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; ANIMAL; ANIMAL BEHAVIOR; CELL LINE; DRUG EFFECT; METABOLISM; NERVE CELL; PHYSIOLOGY;

ANIMALIA;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; APOPTOSIS; BEHAVIOR, ANIMAL; BIOLOGICAL MARKERS; CELL DEATH; CELL LINE; DOPAMINE; ERYTHROPOIETIN; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; NEURONS; NEUROPROTECTIVE AGENTS; NEUROTOXINS; OXIDOPAMINE; PROTO-ONCOGENE PROTEINS C-AKT;

EID: 33644878799     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2005.03587.x     Document Type: Article

References (66)

1. Andersen JK. 2001 Does neuronal loss in Parkinson's disease involve programmed cell death? Bioessays 23 640 646
2. Bellacosa A. Chan TO. Ahmed NN. Datta K. Malstrom S. Stokoe D. McCormick F. Feng JN. Tsichlis P. 1998 Akt activation by growth factors is a multiple-step process: the role of the PH domain Oncogene 17 313 325
3. Bensadoun JC. Deglon N. Tseng JL. Ridet JL. Zurn AD. Aebischer P. 2000 Lentiviral vectors as a gene delivery system in the mouse midbrain: Cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF ExpNeurol 164 15 24
4. de Bernardo S. Canals S. Casarejos MJ. Solano RM. Menendez J. Mena MA. 2004 Role of extracellular signal-regulated protein kinase in neuronal cell death induced by glutathione depletion in neuron/glia mesencephalic cultures JNeurochem 91 667 682
5. Brines ML. Ghezzi P. Keenan S. Agnello D. de Lanerolle NC. Cerami C. Itri LM. Cerami A. 2000 Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury ProcNatl AcadSciUSA 97 10 526 10 531
6. Burgering BMT. Coffer PJ. 1995 Protein kinase-B (C-Akt) in phosphatidylinositol-3-Oh Kinase q24 signal transduction Nature 376 599 602
7. Byrd J. C. Alho H. 1987 Differentiation of PC12 pheochromocytoma cells by sodium butyrate Brain Res 428 151 155
8. Cardone M. Roy N. Stennicke H. Stanbridge E. Franke T. Salvesen G. Reed J. 1998 Regulation of cell death protease caspase-9 by Akt-mediated protein phosphorylation MolBiolCell 9 246a 246a
9. Chavez JC. LaManna JC. 2002 Activation of hypoxia-inducible factor-1 in the rat cerebral cortex after transient global ischemia: Potential role of insulin-like growth factor-1 JNeurosci 22 8922 8931
10. Chen G. Bower KA. Ma CL. Fang SY. Thiele CJ. Luo J. 2004 Glycogen synthase kinase 3 beta (GSK3 beta) mediates 6-hydroxydopamine-induced neuronal death FASEB J 18 1162 1164
11. Chen J. Nagayama T. Jin K. Stetler RA. Zhu RL. Graham SH. Simon RP. 1998 Induction of caspase-3-like protease may mediate delayed neuronal death in the hippocampus after transient cerebral ischemia JNeurosci 18 4914 4928
12. Chong ZZ. Kang JQ. Maiese K. 2002 Hematopoietic factor erythropoietin fosters neuroprotection through novel signal transduction cascades JCerebBlood Flow Metab 22 503 514
13. Chong ZZ. Kang JQ. Maiese K. 2003a Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, Akt1 and Bad, caspase-mediated pathways BrJPharmacol 138 1107 1118
14. Chong ZZ. Lin SH. Kang JQ. Maiese K. 2003b Erythropoietin prevents early and late neuronal demise through modulation of Akt1 and induction of caspase 1, 3, 8 JNeurosciRes 71 659 669
15. Cowen T. 2002 Selective vulnerability in adult and ageing mammalian neurons AutonNeurosciq25 96 20 24
16. Cross DAE. Alessi DR. Cohen P. Andjelkovich M. Hemmings BA. 1995 Inhibition of glycogen-synthase kinase-3 by insulin mediated by protein-kinase-Bq26 Nature 378 785 789
17. Csete M. Rodriguez L. Wilcox M. Chadalavada S. 2004 Erythropoietin receptor is expressed on adult rat dopaminergic neurons and erythropoietin is neurotrophic in cultured dopaminergic neuroblasts NeurosciLett 359 124 126
18. Datta SR. Dudek H. Tao X. Masters S. Fu HA. Gotoh Y. Greenberg ME. 1997 Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery Cell 91 231 241
19. Defazio G. Soleo L. Zefferino R. Livrea P. 1996 Manganese toxicity in serumless dissociated mesencephalic and striatal primary culture Brain ResBull 40 257 262
20. Digicaylioglu M. Lipton SA. 2001 Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappa B signaling cascades Nature 412 641 647
21. Digicaylioglu M. Bichet S. Marti HH. Wenger RH. Rivas LA. Bauer C. Gassmann M. 1995 Localization of specific erythropoietin binding-sites in defined areas of the mouse-brain ProcNatl AcadSciUSA 92 3717 3720
22. Ding YM. Jaumotte JD. Signore AP. Zigmond MJ. 2004 Effects of 6-hydroxydopamine on primary cultures of substantia nigra: specific damage to dopamine neurons and the impact of glial cell line-derived neurotrophic factor JNeurochem 89 776 787
23. Dirnagl U. Simon RP. Hallenbeck JM. 2003 Ischemic tolerance and endogenous neuroprotection Trends Neurosci 26 248 254
24. Dolcet X. Soler RM. Gould TW. Egea J. Oppenheim RW. Comella JX. 2001 Cytokines promote motoneuron survival through the janus kinase-dependent activation of the phosphatidylinositol 3-kinase pathway MolCell Neurosci 18 619 631
25. Dodel RC. Du Y. Bales KR. Ling Z. Carvey PM. Paul SM. 1999 Caspase-3-like proteases and 6-hydroxydopamine induced neuronal cell death Brain ResMolBrain Res 64 141 148
26. Ehrenreich H. Hasselblatt M. Dembowski C. et al. 2002 Erythropoietin therapy for acute stroke is both safe and beneficial MolMed 8 495 505
27. Erbayraktar S. Grasso G. Sfacteria A. et al. 2003 Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo ProcNatl AcadSciUSA 100 6741 6746
28. Genc S. Kuralay F. Genc K. Akhisaroglu M. Fadiloglu S. Yorukoglu K. Fadiloglu M. Gure A. 2001 Erythropoietin exerts neuroprotection in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57/BL mice via increasing nitric oxide production NeurosciLett 298 139 141
29. Hagg T. Varon S. 1993 Ciliary neurotrophic factor prevents degeneration of adult rat substantia nigra dopaminergic neurons in vivo ProcNatl AcadSciUSA 90 6315 6319
30. Han BS. Noh JS. Gwag BJ. Oh YJ. 2003 A distinct death mechanism is induced by 1-methyl-4-phenylpyridinium or by 6-hydroxydopamine in cultured rat cortical neurons: degradation and dephosphorylation of tau NeurosciLett 341 99 102
31. He T. C. Zhou S. B. da Costa LT. Yu J. Kinzler KW. Vogelstein B. 1998 A simplified system for generating recombinant adenoviruses ProcNatl AcadSci. USA 95 2509 2514
32. Hu P. Han Z. Couvillon AD. Exton JH. 2004 Critical role of endogenous Akt/IAPs and MEK1/ERK pathways in counteracting endoplasmic reticulum stress-induced cell death JBiolChem 279 49 420 49 429
33. Kawakami M. Sekiguchi M. Sato K. Kozaki S. Takahashi M. 2001 Erythropoietin receptor-mediated inhibition of exocytotic glutamate release confers neuroprotection during chemical ischemia JBiolChem 276 39 469 39 475
34. Kilic U. Kilic E. Soliz J. Bassetti CL. Gassmann M. Hermann DM. 2005 Erythropoietin protects from axotomy-induced degeneration of retinal ganglion cells by activating ERK-1/-2 FASEB JNeurol 19 249 251
35. Kisseleva T. Bhattacharya S. Braunstein J. Schindler CW. 2002 Signaling through the JAK/STAT pathway, recent advances and future challenges Gene 285 1 24
36. Konishi Y. Chui DH. Hirose H. Kunishita T. Tabira T. 1993 Trophic effect of erythropoietin and other hematopoietic factors on central cholinergic neurons in vitro, in vivo Brain Res 609 29 35
37. Kulich SM. Chu CT. 2001 Sustained extracellular signal-regulated kinase activation by 6-hydroxydopamine: implications for Parkinson's disease JNeurochem 77 1058 1066
38. Larsen KE. Fon EA. Hastings TG. Edwards RH. Sulzer D. 2002 Methamphetamine-induced degeneration of dopaminergic neurons involves autophagy and upregulation of dopamine synthesis JNeurosci 22 8951 8960
39. Lee JY. Koh HC. Chang MY. Park CH. Lee YS. Lee SH. 2003 Erythropoietin and bone morphogenetic protein 7 mediate ascorbate-induced dopaminergic differentiation from embryonic mesencephalic precursors Neuroreport 14 1401 1404
40. Leist M. Ghezzi P. Grasso G. et al. 2004 Derivatives of erythropoietin that are tissue protective but not erythropoeitic Science 305 239 242
41. Liang QH. Liou AKF. Ding YM. Cao GD. Xiao X. Perez RG. Chen J. 2004 6-hydroxydopamine induces dopaminergic cell degeneration via a caspase-9-mediated apoptotic pathway that is attenuated by caspase-9dn expression JNeurosciRes 77 747 761
42. Liou AK. Clark RS. Henshall DC. Yin XM. Chen J. 2003 To die or not to die for neurons in ischemia, traumatic brain injury and epilepsy: a review on the stress-activated signaling pathways and apoptotic pathways ProgNeurobiol 69 103 142
43. Lotharius J. Dugan LL. O'Malley KL. 1999 Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons JNeurosci 19 1284 1293
44. Macdougall IC. Matcham J. Gray SJ. Grp NS. 2003 Correction of anaemia with darbepoetin alfa in patients with chronic kidney disease receiving dialysis NephrolDialTranspl 18 576 581
45. Maiese K. Li FQ. Chong ZZ. 2004 Erythropoietin in the brain: can the promise to protect be fulfilled? Trends PharmacolSci 25 577 583
46. Marti HH. 2004 Erythropoietin and the hypoxic brain JExpBiol 207 3233 3242
47. Masuda S. Okano M. Yamagishi K. Nagao M. Ueda M. Sasaki R. 1994 A novel site of erythropoietin production-oxygen-dependent production in cultured rat astrocytes JBiolChem 269 19 488 19 493
48. Nair VD. Olanow CW. Sealfon SC. 2003 Activation of phosphoinositide 3-kinase by D-2 receptor prevents apoptosis in dopaminergic cell lines BiochemJ 373 25 32
49. Ochu EE. Rothwell NJ. Waters CM. 1998 Caspases mediate 6-hydroxydopamine-induced apoptosis but not necrosis in PC12 cells JNeurochem 70 2637 2640
50. Oh YJ. Wong SC. Moffat M. O'Malley KL. 1995 Overexpression of Bcl-2 attenuates MPP+, but not 6-ODHA, induced cell death in a dopaminergic neuronal cell line NeurobiolDis 2 157 167
51. Rao RV. Hermel E. Castro-Obregon S. del Rio G. Ellerby LM. Ellerby HM. Bredesen DE. 2001 Coupling endoplasmic reticulum stress to the cell death program - Mechanism of caspase activation JBiolChem 276 33869 33874
52. Romashkova JA. Makarov SS. 1999 NF-kappa B is a target of AKT in anti-apoptotic PDGF signalling Nature 401 86 90
53. Ryu EJ. Harding HP. Angelastro JM. Vitolo OV. Ron D. Greene LA. 2002 Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson's disease JNeurosci 22 10 690 10 698
54. Salinas M. Diaz R. Abraham NG. de Galarreta CMR. Cuadrado A. 2003 Nerve growth factor protects against 6-hydroxydopamine-induced oxidative stress by increasing expression of heme oxygenase-1 in a phosphatidylinositol 3-kinase-dependent manner JBiolChem 278 13 898 13 904
55. Sättler MB. Merkler D. Maier K. Stadelmann C. Ehrenreich H. Bahr M. Diem R. 2004 Neuroprotective effects and intracellular signaling pathways of erythropoietin in a rat model of multiple sclerosis, in Cell Death Differ 1 S181 S192
56. Shingo T. Sorokan ST. Shimazaki T. Weiss S. 2001 Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells JNeurosci 21 9733 9743
57. Siren AL. Fratelli M. Brines M. et al. 2001 Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress ProcNatl AcadSciUSA 98 4044 4049
58. Son JH. Chun HS. Joh TH. Cho S. Conti B. Lee JW. 1999 Neuroprotection and neuronal differentiation studies using substantia nigra dopaminergic cells derived from transgenic mouse embryos JNeurosci 19 10 20
59. Stanciu M. Wang Y. Kentor R. et al. 2000 Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures JBiolChem 275 12 200 12 206
60. Stocchi F. Olanow CW. 2003 Neuroprotection in Parkinson's disease: clinical trials AnnNeurol 53 S87 S97
61. Studer L. Csete M. Lee SH. Kabbani N. Walikonis J. Wold B. McKay R. 2000 Enhanced proliferation, survival and dopaminergic differentiation of CNS precursors in lowered oxygen JNeurosci 20 7377 7383
62. Tatton WG. Chalmers-Redman R. Brown D. Tatton N. 2003 Apoptosis in Parkinson's disease: signals for neuronal degradation AnnNeurol 53 S61 S70
63. Tomac A. Lindqvist E. Lin LFH. Ogren SO. Young D. Hoffer BJ. Olson L. 1995 Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo Nature 373 335 339
64. Ugarte SD. Lin E. Klann E. Zigmond MJ. Perez RG. 2003 Effects of GDNF on 6-OHDA-induced death in a dopaminergic cell line: modulation by inhibitors of PI3 kinase and MEK JNeurosciRes 73 105 112
65. Xia ZG. Dickens M. Raingeaud J. Davis RJ. Greenberg ME. 1995 Opposing effects of Erk and Jnk-P38 Map kinases on apoptosis Science 270 1326 1331
66. Zhang L. Schallert T. Zhang ZG. Jiang Q. Arniego P. Li QJ. Lu M. Chopp M. 2002 A test for detecting long-term sensorimotor dysfunction in the mouse after focal cerebral ischemia JNeurosciMeth 117 207 214